Literature DB >> 17309811

From ancient medicine to modern medicine: ayurvedic concepts of health and their role in inflammation and cancer.

Prachi Garodia1, Haruyo Ichikawa, Nikita Malani, Gautam Sethi, Bharat B Aggarwal.   

Abstract

Recent statistics indicate that the overall cancer incidence in the United States, in spite of billions of dollars spent on research each year, has not changed significantly in the last half-century. Cancers of the prostate, breast, lung, and colon, although most common in the Western world, are least common in the Eastern world. Allopathic medicine commonly practiced currently is only 100 years old. Although traditional medicine has been around for thousands of years, no integration exists between it and allopathic medicine. Ayurveda, the science of long life and one of the most ancient medical systems still practiced on the Indian subcontinent, can be used in combination with modern medicine to provide better treatment of cancer. This review focuses on the ayurvedic concept of the causes of cancer and its linkage with inflammation, diagnosis, prevention, and treatment. How ayurvedic medicine can be integrated with allopathic medicine is also discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309811     DOI: 10.2310/7200.2006.029

Source DB:  PubMed          Journal:  J Soc Integr Oncol        ISSN: 1715-894X


  46 in total

1.  [Aspects of traditional Indian medicine (Ayurveda) in urology].

Authors:  J Mani; S Kumar; G J Dobos; A Haferkamp
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

2.  Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression.

Authors:  Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Cancer Lett       Date:  2012-08-27       Impact factor: 8.679

3.  Naphthoquinone components from Alkanna tinctoria (L.) Tausch show significant antiproliferative effects on human colorectal cancer cells.

Authors:  Nguyen Huu Tung; Guang-Jian Du; Chong-Zhi Wang; Chun-Su Yuan; Yukihiro Shoyama
Journal:  Phytother Res       Date:  2012-04-04       Impact factor: 5.878

4.  Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells.

Authors:  Eun-Ryeong Hahm; Joomin Lee; Shivendra V Singh
Journal:  Mol Carcinog       Date:  2013-09-09       Impact factor: 4.784

5.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

Review 6.  Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone.

Authors:  Avani R Vyas; Shivendra V Singh
Journal:  AAPS J       Date:  2013-09-18       Impact factor: 4.009

Review 7.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

8.  Building bridges between Ayurveda and Modern Science.

Authors:  Sanjeev Rastogi
Journal:  Int J Ayurveda Res       Date:  2010-01

9.  Curcuminoids as inhibitors of thioredoxin reductase: a receptor based pharmacophore study with distance mapping of the active site.

Authors:  Durg Vijay Singh; Krishna Misra
Journal:  Bioinformation       Date:  2009-10-24

10.  Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.

Authors:  Joomin Lee; Eun-Ryeong Hahm; Adam I Marcus; Shivendra V Singh
Journal:  Mol Carcinog       Date:  2013-11-30       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.